Baxter International News
Most Popular Baxter International Story
UPDATED: Baxter, Momenta team up in potential $452M biosimilars deal
Drugmakers and biotech groups continue to partner up in the biosimilars game. With plans to develop up to 6 knockoffs of biologic drugs, Baxter International ($BAX) has agreed to pay Momenta Read more...
Latest Headlines
- December 22, 2011
- September 8, 2011
- April 18, 2011
- March 18, 2009
- April 18, 2008
- April 1, 2008
- August 29, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
